Related references
Note: Only part of the references are listed.Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial
Siegfried Kasper et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2009)
Pregabalin in the discontinuation of long-term benzodiazepines' use
Panagiotis Oulis et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2008)
Pregabalin in the discontinuation of long-term benzodiazepine use: a case-series
Panagiotis Oulis et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2008)
Risk of road traffic accidents associated with the prescription of drugs: A registry-based cohort study
Anders Engeland et al.
ANNALS OF EPIDEMIOLOGY (2007)
Ca2+ channel α2δ ligands:: novel modulators of neurotransmission
David J. Dooley et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Clinical application of paroxetine for tapering benzodiazepine use in non-major-depressive outpatients visiting an internal medicine clinic
Mutsuhiro Nakao et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2006)
Pregabalin for the treatment of generalised anxiety disorder
Stuart A. Montgomery
EXPERT OPINION ON PHARMACOTHERAPY (2006)
Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: Results from the national epidemiologic survey on alcohol and related conditions
KP Conway et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
A double-blind, placebo- and positive-internal-controlled (alprazolam) investigation of the cognitive and psychomotor profile of pregabalin in healthy volunteers
I Hindmarch et al.
PSYCHOPHARMACOLOGY (2005)
Long-term use of benzodiazepines in participants with comorbid anxiety and alcohol use disorders
TI Mueller et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2005)
Prescription psychotropic medication use among the US adult population: results from the third National Health and Nutrition Examination Survey, 1988-1994
R Paulose-Ram et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2004)
Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo-controlled study
G Gerra et al.
ADDICTION BIOLOGY (2002)
The PHQ-9: A new depression diagnostic and severity measure
K Kroenke et al.
PSYCHIATRIC ANNALS (2002)
Cognitive and sedative effects of benzodiazepine use
SE Buffett-Jerrott et al.
CURRENT PHARMACEUTICAL DESIGN (2002)
Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy
K Rickels et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)